Book chapter · 2025

Challenges for Commercial Translation of Nanomedicines

Ajay Jaysingh Khopade, Malay D. Shah

CRC Press eBooks, 1–40 · Published 25 June 2025 · DOI 10.1201/9781003482826-1

View at the publisherCite this paper

In brief

“Challenges for Commercial Translation of Nanomedicines” is a 2025 book chapter by Ajay Jaysingh Khopade and Malay D. Shah, published in CRC Press eBooks. OpenAlex counts 23 citations as of 20 November 2026, which puts it in the top 3% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
23
Most cited in
2026 (18)
Field-weighted impact
23.49
Authors
2

Abstract

This chapter explores the critical obstacles involved in transforming nanomedicines from laboratory research to commercial viability. It highlights the complexities in scaling up manufacturing process while maintaining quality, reproducibility, and cost efficiency. The discussion delves into challenges in the robust characterization of nanomaterials, requiring advanced analytical tools to ensure consistency in size, surface properties, and… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Khopade, A. J., & Shah, M. D. (2025). Challenges for Commercial Translation of Nanomedicines. CRC Press eBooks, 1–40. https://doi.org/10.1201/9781003482826-1

MLA 9

Khopade, Ajay Jaysingh, and Malay D. Shah. “Challenges for Commercial Translation of Nanomedicines.” CRC Press eBooks, 2025, pp. 1–40. https://doi.org/10.1201/9781003482826-1.

Chicago

Khopade, Ajay Jaysingh and Malay D. Shah. 2025. “Challenges for Commercial Translation of Nanomedicines.” CRC Press eBooks: 1–40. https://doi.org/10.1201/9781003482826-1.

Harvard

Khopade, A. J. and Shah, M. D. (2025) ‘Challenges for Commercial Translation of Nanomedicines’, CRC Press eBooks, pp. 1–40. doi:10.1201/9781003482826-1.

IEEE

A. J. Khopade and M. D. Shah, “Challenges for Commercial Translation of Nanomedicines,” CRC Press eBooks, pp. 1–40, 2025, doi: 10.1201/9781003482826-1.

BibTeX

@incollection{khopade2025challenges,
  title     = {{Challenges for Commercial Translation of Nanomedicines}},
  author    = {Khopade, Ajay Jaysingh and Shah, Malay D.},
  booktitle = {CRC Press eBooks},
  publisher = {CRC Press},
  year      = {2025},
  pages     = {1--40},
  doi       = {10.1201/9781003482826-1},
  url       = {https://doi.org/10.1201/9781003482826-1}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • nanomedicine
  • commercialization
  • scalable fabrication
  • nanomaterial characterization
  • preclinical animal models
  • clinical trial design
  • regulatory approval
  • regulatory harmonization

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Khopade, A. J., & Shah, M. D. (2025). Challenges for Commercial Translation of Nanomedicines. CRC Press eBooks, 1–40. https://doi.org/10.1201/9781003482826-1

How many times has this paper been cited?

23 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Ajay Jaysingh Khopade, Malay D. Shah.

What is the DOI of this paper?

10.1201/9781003482826-1, permanently at https://doi.org/10.1201/9781003482826-1. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.